Atlassian Jumps 24% on Q3 Earnings Blowout and AI Momentum
Atlassian stock surged 24% after Q3 FY2026 results crushed estimates — revenue hit $1.79B (+32% YoY), non-GAAP EPS of $1.75 beat by 34%, and Rovo AI credits grew 20%+ monthly.
Atlassian stock surged 24% after Q3 FY2026 results crushed estimates — revenue hit $1.79B (+32% YoY), non-GAAP EPS of $1.75 beat by 34%, and Rovo AI credits grew 20%+ monthly.
Merck Q1 2026: $16.3B revenue beat, guidance raised. A $9B acquisition charge drove a GAAP loss, but Winrevair growth signals strong underlying fundamentals.
Eli Lilly beat Q1 2026 estimates with $19.8B revenue (+56%), EPS of $8.26 (+170%), driven by Mounjaro, Zepbound, and newly launched oral pill Foundayo.
NXP Semiconductors surged 26% — its best day since listing in 2010 — as Q1 earnings beat estimates and Q2 guidance of up to $3.55B signaled a chip recovery led by auto and AI.
Meta, Alphabet, Amazon, and Microsoft posted Q1 2026 earnings beats this week—combined revenues hit $430 billion as AI investments begin delivering measurable results across the board.
Bloom Energy (BE) surges 23% after Q1 2026 revenue jumps 130% to $751M on AI data center demand; full-year revenue guidance raised to $3.4B–$3.8B.
Coca-Cola reported $12.47B in Q1 2026 revenue — up 12% year-over-year — and raised its full-year profit forecast, sending KO shares up 3.86% on the session.
Apple reports Q2 FY2026 earnings April 30 with analysts expecting $108.9B in revenue and $1.93 EPS. Key themes: Services momentum, AI-driven iPhone upgrades, and tariff headwinds.
AMETEK is in exclusive talks to buy Indicor valve and pump units from CD&R for ~$5B, potentially its largest-ever acquisition.
Spotify stock fell 13% after Q1 2026 results as soft Q2 subscriber and profit guidance overshadowed a strong profit beat and 40% operating income growth.